Senior insider sale
Chief Financial Officer at PROTAGONIST THERAPEUTICS, INC — senior position signals high conviction
$4.55M
54.79K shares
What this filing means
ALI ASIF plans to sell 54.79K shares of PROTAGONIST THERAPEUTICS, INC valued at approximately $4.55M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/27/2026ACC: 0001950047-26-000710
Officer· Chief Financial Officer
Since Apr 2022
54.79K
Shares to sell
$4.55M
Approx. market value
46.20K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months7
Stock Option Exercise
Cash
1/27/2026
28KRestricted Stock
Not Applicable
1/15/2026
3.98KRestricted Stock
Not Applicable
1/15/2026
2.21KRestricted Stock
Not Applicable
1/15/2026
3.71KRestricted Stock
Not Applicable
4/18/2025
1.68KRestricted Stock
Not Applicable
1/15/2025
2.23KRestricted Stock
Not Applicable
1/15/2025
4.40KTotal acquired46.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/27/2026 | Stock Option Exercise Cash | 28K | — |
1/15/2026 | Restricted Stock Not Applicable | 3.98K | — |
1/15/2026 | Restricted Stock Not Applicable | 2.21K | — |
1/15/2026 | Restricted Stock Not Applicable | 3.71K | — |
4/18/2025 | Restricted Stock Not Applicable | 1.68K | — |
1/15/2025 | Restricted Stock Not Applicable | 2.23K | — |
1/15/2025 | Restricted Stock Not Applicable | 4.40K | — |
| Total | 46.20K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
8.59K
Market value
$708.3K
1/20/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
46.20K
Market value
$3.84M
1/27/2026
Total
Units
54.79K
Value
$4.55M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/20/2026 | 8.59K | $708.3K | — | Completed |
| Planned — Approximate Date | ||||
1/27/2026 | 46.20K | $3.84M | NASDAQ | Planned |
| Total | 54.79K | $4.55M | ||